DRUG DEVELOPMENT
poor execution
CAN KILL
YOUR IDEA
"Chemistry Manufacturing and Control" is the most underappreciated aspect of the whole drug development process, but it can make or break development!
“Don’t underestimate
the whole value chain of CMC"
The ''BpiFrance Health Tech 2021 plan'' highlights
the weakness of execution
in the drug development chain
by emerging biotechs.
In the last few years, several French biotechs
have faced difficulties on these execution issues,
despite their undisputed clinical potential.
WHO WE ARE
3BIOTECH is a fully independent, privately owned, drug development focused company, located in Paris, France, operating all over Europe.
3Biotech offers a premium service focused
on 3 majors pillars in drug development
# Safety # Efficacy # Manufacturability
dedicated to biotechs startups in the long run,
for building a full “Chemistry Manufacturing
and Control” strategy.
25 years experience in pharma industry,
started 3Biotech to accelerate the growth of
innovation on the Biopharma area.
“Bringing a drug to market is a cross-functional project. It must be planned and executed in
a transversal manner. We think we can improve the lives of patients and the future of healthcare
by accelerating the growth
of biopharma companies.
We are a strong support on the field,
“From Science to First in Human.”
Olivier Favre-Bulle,
CEO and founder
Bringing a drug to market
is a cross-functional project
We are not a consultancy firm, but an accelerator.
See us as members of your team focused on your performance, able to maintain pharmaceutical industry’s high level standards.
Our drug development approach is based on 3 major pillars
we are your first crash test
our first job is to challenge you
Our mission is to understand, to challenge and to unleash
health tech entrepreneurs. 3Biotech will support you from discovering your drug candidate to the clinical proof of concept.
OUR CLIENTS
3Biotech works for companies now considered leaders
in the pharmaceutical industry and health investment funds.
2021 FIGURES
79
Projects
8
MoLecules
In PHASE 1
3
MoLEcules
In PHASE 2
2
MoLecules
IN PHASE 3
96%
CUSTOMER
SATISFACTION
on execution
"DOES YOUR CMC STRATEGY
MATCH THE VALUE
OF YOUR INNOVATION?"
Never forget : great ideas failed due to bad execution. Beware of shortcuts! "Let’s run as fast as we can” is not an option…
WE ARE YOUR BEST SUPPORT ON THE FIELD
FROM SCIENCE TO FIRST IN HUMAN
CONTACT US
66 avenue des Champs-Élysées, 75008 Paris - France
+ 33 (0)1 76 50 40 45
